172 related articles for article (PubMed ID: 38672067)
1. Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification.
Chiba T
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672067
[TBL] [Abstract][Full Text] [Related]
2. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
3. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
4. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
J D
Cesk Patol; 2024; 60(1):59-63. PubMed ID: 38697828
[TBL] [Abstract][Full Text] [Related]
5. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Jung CK; Bychkov A; Kakudo K
Endocrinol Metab (Seoul); 2022 Oct; 37(5):703-718. PubMed ID: 36193717
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.
Poma AM; Macerola E; Ghossein RA; Tallini G; Basolo F
Thyroid; 2024 Mar; 34(3):314-323. PubMed ID: 38115626
[No Abstract] [Full Text] [Related]
7. [Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance].
Liu LP; Hao JY; Pan H; Wang C; Yue P
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):256-261. PubMed ID: 32187898
[No Abstract] [Full Text] [Related]
8. Classification of Thyroid Tumors Based on DNA Methylation Patterns.
Marczyk VR; Recamonde-Mendoza M; Maia AL; Goemann IM
Thyroid; 2023 Sep; 33(9):1090-1099. PubMed ID: 37392021
[No Abstract] [Full Text] [Related]
9. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
10. Mutation profiles of follicular thyroid tumors by targeted sequencing.
Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
12. [Pathology and molecular profile of differentiated thyroid carcinoma].
Theurer S; Rawitzer J; Schmid KW
Chirurg; 2020 Dec; 91(12):999-1006. PubMed ID: 32813026
[TBL] [Abstract][Full Text] [Related]
13. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
14. A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.
Romei C; Elisei R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572167
[TBL] [Abstract][Full Text] [Related]
15. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
[TBL] [Abstract][Full Text] [Related]
16. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading.
Christofer Juhlin C; Mete O; Baloch ZW
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36445235
[TBL] [Abstract][Full Text] [Related]
17. The contribution of molecular pathology to the classification of thyroid tumors.
Xu B; Ghossein RA
Diagn Histopathol (Oxf); 2018 Mar; 24(3):87-94. PubMed ID: 34017360
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression in rare and aggressive thyroid cancers: A preliminary investigation for a role of immunotherapy.
Boruah M; Gaddam P; Agarwal S; Mir RA; Gupta R; Sharma MC; S Deo SV; Nilima N
J Cancer Res Ther; 2023; 19(2):312-320. PubMed ID: 37006068
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions.
Sadullahoğlu C; Sayıner A; Süren D; Yıldırım HT; Nergiz D; Sezer C; Oruç MT
Indian J Pathol Microbiol; 2019; 62(2):206-210. PubMed ID: 30971541
[TBL] [Abstract][Full Text] [Related]
20. How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.
Kakudo K
Gland Surg; 2018 Aug; 7(Suppl 1):S8-S18. PubMed ID: 30175059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
